The effects of cervical application of inhibitors of inducible nitric oxide synthase, cyclooxygenase-1, and cyclooxygenase-2 on delivery in rats

Objective: To investigate the effect of cervical application of nonselective and selective inhibitors of nitric oxide synthases—N -nitro-L -arginine methyl ester, L -N -iminoethyl-lysine, and aminoguanidine—as well as inhibitors of cyclooxygenases—indomethacin, and nimesulide—on timing of delivery a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of obstetrics and gynecology 2001-10, Vol.185 (4), p.959-965
Hauptverfasser: Bukowski, Radoslaw, McKay, Lynn, Shi, Shao-Qing, Saade, George R., Garfield, Robert E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 965
container_issue 4
container_start_page 959
container_title American journal of obstetrics and gynecology
container_volume 185
creator Bukowski, Radoslaw
McKay, Lynn
Shi, Shao-Qing
Saade, George R.
Garfield, Robert E.
description Objective: To investigate the effect of cervical application of nonselective and selective inhibitors of nitric oxide synthases—N -nitro-L -arginine methyl ester, L -N -iminoethyl-lysine, and aminoguanidine—as well as inhibitors of cyclooxygenases—indomethacin, and nimesulide—on timing of delivery and fetal death and disease in pregnant rats. Study Design: In a series of experimental protocols, timed-pregnant Sprague-Dawley rats (length of pregnancy, 22 days) were randomly allocated to daily cervical applications of (1) 0.04 mg (n = 6), 0.4 mg (n = 6), 4 mg (n = 6), or 40 mg (n = 6) L -N -iminoethyl-lysine or vehicle (n = 12) on days 19 to 22 of pregnancy; (2) 50 mg aminoguanidine (n = 6), 150 mg aminoguanidine (n = 6), or vehicle (n = 10) on days 19 to 22 of pregnancy; (3) 3 mg indomethacin (n = 6) or vehicle (n = 6) on days 19 to 22 of pregnancy; (4) 12.5 mg/kg nimesulide (n = 8), 25 mg/kg nimesulide (n = 8), 50 mg/kg nimesulide (n = 12), or vehicle (n = 12) on days 19 to 22 of pregnancy and 50 mg/kg nimesulide (n = 23) or vehicle (n = 23) on days 14 to 22 of pregnancy; (5) 50 mg/kg nimesulide (n = 10), 50 mg aminoguanidine plus 50 mg/kg nimesulide (n = 10), 50 mg aminoguanidine (n = 10), or vehicle (n = 10) on days 14 to 22 of pregnancy. The following variables were evaluated: proportion of animals that were delivered on day 23, time to delivery of the first pup (midnight on day 22 was considered to be 0 hour), number of stillborn pups, and average pup weight of each litter. Results: Unlike L -N -iminoethyl-lysine, aminoguanidine, and indomethacin, 50 mg/kg nimesulide applied on the cervix daily for 8 days significantly increased the proportion of animals that were delivered on day 23 (18 of 23 versus 7 of 23; P =.003) and the time to delivery of the first pup by a mean of 10.8 hours (P
doi_str_mv 10.1067/mob.2001.116723
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72215979</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002937801446011</els_id><sourcerecordid>72215979</sourcerecordid><originalsourceid>FETCH-LOGICAL-c373t-50581d3ae4e19ceb4ad0a36213cea5e3ec8c300ecc34c9ea6c50ca67e398ae813</originalsourceid><addsrcrecordid>eNp1kUtrHDEQhEVwiDdOzr4ZXZyTZ63HvHQMS-wEDL44Z6Fp9WRlZqW1NLt4_oV_cjTMgiGQU6uarwtRRcglZ2vO6uZ2F7q1YIyvOa8bIT-QFWeqKeq2bs_IijEmCiWb9px8Tul5lkKJT-Q80yWv22pF3p62SLHvEcZEQ08B49GBGajZ74f8GF3w8975revcGGJalD2A6wak3o3RAQ2vziJNkx-3JuENhQmGEF6nP-izLvgNNd7-uxU0e1sc3BHjlD1pNGP6Qj72Zkj49TQvyO-7H0-bn8XD4_2vzfeHAmQjx6JiVcutNFgiV4BdaSwzshZcApoKJUILkjEEkCUoNDVUDEzdoFStwZbLC_Jt8d3H8HLANOqdS4DDYDyGQ9KNELxSjcrg7QJCDClF7PU-up2Jk-ZMzyXoXIKeS9BLCfni6mR96HZo3_lT6hm4PgEm5az7aDy49M6VTPGqnI3UwmEO4ugw6gQOPaB1MRembXD__cRfMaSl9A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72215979</pqid></control><display><type>article</type><title>The effects of cervical application of inhibitors of inducible nitric oxide synthase, cyclooxygenase-1, and cyclooxygenase-2 on delivery in rats</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Bukowski, Radoslaw ; McKay, Lynn ; Shi, Shao-Qing ; Saade, George R. ; Garfield, Robert E.</creator><creatorcontrib>Bukowski, Radoslaw ; McKay, Lynn ; Shi, Shao-Qing ; Saade, George R. ; Garfield, Robert E.</creatorcontrib><description>Objective: To investigate the effect of cervical application of nonselective and selective inhibitors of nitric oxide synthases—N -nitro-L -arginine methyl ester, L -N -iminoethyl-lysine, and aminoguanidine—as well as inhibitors of cyclooxygenases—indomethacin, and nimesulide—on timing of delivery and fetal death and disease in pregnant rats. Study Design: In a series of experimental protocols, timed-pregnant Sprague-Dawley rats (length of pregnancy, 22 days) were randomly allocated to daily cervical applications of (1) 0.04 mg (n = 6), 0.4 mg (n = 6), 4 mg (n = 6), or 40 mg (n = 6) L -N -iminoethyl-lysine or vehicle (n = 12) on days 19 to 22 of pregnancy; (2) 50 mg aminoguanidine (n = 6), 150 mg aminoguanidine (n = 6), or vehicle (n = 10) on days 19 to 22 of pregnancy; (3) 3 mg indomethacin (n = 6) or vehicle (n = 6) on days 19 to 22 of pregnancy; (4) 12.5 mg/kg nimesulide (n = 8), 25 mg/kg nimesulide (n = 8), 50 mg/kg nimesulide (n = 12), or vehicle (n = 12) on days 19 to 22 of pregnancy and 50 mg/kg nimesulide (n = 23) or vehicle (n = 23) on days 14 to 22 of pregnancy; (5) 50 mg/kg nimesulide (n = 10), 50 mg aminoguanidine plus 50 mg/kg nimesulide (n = 10), 50 mg aminoguanidine (n = 10), or vehicle (n = 10) on days 14 to 22 of pregnancy. The following variables were evaluated: proportion of animals that were delivered on day 23, time to delivery of the first pup (midnight on day 22 was considered to be 0 hour), number of stillborn pups, and average pup weight of each litter. Results: Unlike L -N -iminoethyl-lysine, aminoguanidine, and indomethacin, 50 mg/kg nimesulide applied on the cervix daily for 8 days significantly increased the proportion of animals that were delivered on day 23 (18 of 23 versus 7 of 23; P =.003) and the time to delivery of the first pup by a mean of 10.8 hours (P &lt;.001). Shorter treatment with nimesulide for 4 days increased only the time to delivery of the first pup at the 25-mg/kg dosage (P =.008). Simultaneous application of aminoguanidine and nimesulide significantly (P =.008) prolonged pregnancy to a degree similar to nimesulide alone. The experiment with N -nitro-L -arginine methyl ester was aborted because of severe maternal side effects. Unlike pups in the L -N -iminoethyl-lysine, aminoguanidine, and nimesulide groups, significantly more pups in the indomethacin group died in utero compared with the control group (36.1% versus 3.1%; P &lt;.001), and the surviving pups had lower birth weights (P &lt;.001). Conclusions: In an animal model, nimesulide was effective in delaying the onset of labor, was well tolerated during pregnancy, and affected cervical ripening directly independent of progesterone withdrawal. Conversely, cervical application of nitric oxide synthase and nonselective cyclooxygenase inhibitors do not extend the duration of pregnancy in the dosages studied, and some are associated with significant adverse effects in the mothers and fetuses. (Am J Obstet Gynecol 2001;185: 959-65.)</description><identifier>ISSN: 0002-9378</identifier><identifier>EISSN: 1097-6868</identifier><identifier>DOI: 10.1067/mob.2001.116723</identifier><identifier>PMID: 11641685</identifier><identifier>CODEN: AJOGAH</identifier><language>eng</language><publisher>Philadelphia, PA: Mosby, Inc</publisher><subject>Administration, Topical ; Animals ; Biological and medical sciences ; cervical ripening ; Cervical Ripening - drug effects ; Cervix Uteri - drug effects ; Cervix Uteri - physiology ; cyclooxygenase inhibitor ; Cyclooxygenase Inhibitors - pharmacology ; Delivery, Obstetric - methods ; Female ; Fetal Death ; Genital system. Reproduction ; Guanidines - pharmacology ; Indomethacin - pharmacology ; Inhibition ; Medical sciences ; Models, Animal ; NG-Nitroarginine Methyl Ester - administration &amp; dosage ; nitric oxide synthase inhibitor ; Pharmacology. Drug treatments ; Pregnancy ; Pregnancy Outcome ; Pregnancy, Animal ; preterm delivery ; Probability ; Rats ; Rats, Sprague-Dawley ; Sensitivity and Specificity ; Statistics, Nonparametric ; Sulfonamides - pharmacology ; Treatment Outcome</subject><ispartof>American journal of obstetrics and gynecology, 2001-10, Vol.185 (4), p.959-965</ispartof><rights>2001 Mosby, Inc.</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c373t-50581d3ae4e19ceb4ad0a36213cea5e3ec8c300ecc34c9ea6c50ca67e398ae813</citedby><cites>FETCH-LOGICAL-c373t-50581d3ae4e19ceb4ad0a36213cea5e3ec8c300ecc34c9ea6c50ca67e398ae813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1067/mob.2001.116723$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,3548,23929,23930,25139,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14091543$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11641685$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bukowski, Radoslaw</creatorcontrib><creatorcontrib>McKay, Lynn</creatorcontrib><creatorcontrib>Shi, Shao-Qing</creatorcontrib><creatorcontrib>Saade, George R.</creatorcontrib><creatorcontrib>Garfield, Robert E.</creatorcontrib><title>The effects of cervical application of inhibitors of inducible nitric oxide synthase, cyclooxygenase-1, and cyclooxygenase-2 on delivery in rats</title><title>American journal of obstetrics and gynecology</title><addtitle>Am J Obstet Gynecol</addtitle><description>Objective: To investigate the effect of cervical application of nonselective and selective inhibitors of nitric oxide synthases—N -nitro-L -arginine methyl ester, L -N -iminoethyl-lysine, and aminoguanidine—as well as inhibitors of cyclooxygenases—indomethacin, and nimesulide—on timing of delivery and fetal death and disease in pregnant rats. Study Design: In a series of experimental protocols, timed-pregnant Sprague-Dawley rats (length of pregnancy, 22 days) were randomly allocated to daily cervical applications of (1) 0.04 mg (n = 6), 0.4 mg (n = 6), 4 mg (n = 6), or 40 mg (n = 6) L -N -iminoethyl-lysine or vehicle (n = 12) on days 19 to 22 of pregnancy; (2) 50 mg aminoguanidine (n = 6), 150 mg aminoguanidine (n = 6), or vehicle (n = 10) on days 19 to 22 of pregnancy; (3) 3 mg indomethacin (n = 6) or vehicle (n = 6) on days 19 to 22 of pregnancy; (4) 12.5 mg/kg nimesulide (n = 8), 25 mg/kg nimesulide (n = 8), 50 mg/kg nimesulide (n = 12), or vehicle (n = 12) on days 19 to 22 of pregnancy and 50 mg/kg nimesulide (n = 23) or vehicle (n = 23) on days 14 to 22 of pregnancy; (5) 50 mg/kg nimesulide (n = 10), 50 mg aminoguanidine plus 50 mg/kg nimesulide (n = 10), 50 mg aminoguanidine (n = 10), or vehicle (n = 10) on days 14 to 22 of pregnancy. The following variables were evaluated: proportion of animals that were delivered on day 23, time to delivery of the first pup (midnight on day 22 was considered to be 0 hour), number of stillborn pups, and average pup weight of each litter. Results: Unlike L -N -iminoethyl-lysine, aminoguanidine, and indomethacin, 50 mg/kg nimesulide applied on the cervix daily for 8 days significantly increased the proportion of animals that were delivered on day 23 (18 of 23 versus 7 of 23; P =.003) and the time to delivery of the first pup by a mean of 10.8 hours (P &lt;.001). Shorter treatment with nimesulide for 4 days increased only the time to delivery of the first pup at the 25-mg/kg dosage (P =.008). Simultaneous application of aminoguanidine and nimesulide significantly (P =.008) prolonged pregnancy to a degree similar to nimesulide alone. The experiment with N -nitro-L -arginine methyl ester was aborted because of severe maternal side effects. Unlike pups in the L -N -iminoethyl-lysine, aminoguanidine, and nimesulide groups, significantly more pups in the indomethacin group died in utero compared with the control group (36.1% versus 3.1%; P &lt;.001), and the surviving pups had lower birth weights (P &lt;.001). Conclusions: In an animal model, nimesulide was effective in delaying the onset of labor, was well tolerated during pregnancy, and affected cervical ripening directly independent of progesterone withdrawal. Conversely, cervical application of nitric oxide synthase and nonselective cyclooxygenase inhibitors do not extend the duration of pregnancy in the dosages studied, and some are associated with significant adverse effects in the mothers and fetuses. (Am J Obstet Gynecol 2001;185: 959-65.)</description><subject>Administration, Topical</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>cervical ripening</subject><subject>Cervical Ripening - drug effects</subject><subject>Cervix Uteri - drug effects</subject><subject>Cervix Uteri - physiology</subject><subject>cyclooxygenase inhibitor</subject><subject>Cyclooxygenase Inhibitors - pharmacology</subject><subject>Delivery, Obstetric - methods</subject><subject>Female</subject><subject>Fetal Death</subject><subject>Genital system. Reproduction</subject><subject>Guanidines - pharmacology</subject><subject>Indomethacin - pharmacology</subject><subject>Inhibition</subject><subject>Medical sciences</subject><subject>Models, Animal</subject><subject>NG-Nitroarginine Methyl Ester - administration &amp; dosage</subject><subject>nitric oxide synthase inhibitor</subject><subject>Pharmacology. Drug treatments</subject><subject>Pregnancy</subject><subject>Pregnancy Outcome</subject><subject>Pregnancy, Animal</subject><subject>preterm delivery</subject><subject>Probability</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Sensitivity and Specificity</subject><subject>Statistics, Nonparametric</subject><subject>Sulfonamides - pharmacology</subject><subject>Treatment Outcome</subject><issn>0002-9378</issn><issn>1097-6868</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUtrHDEQhEVwiDdOzr4ZXZyTZ63HvHQMS-wEDL44Z6Fp9WRlZqW1NLt4_oV_cjTMgiGQU6uarwtRRcglZ2vO6uZ2F7q1YIyvOa8bIT-QFWeqKeq2bs_IijEmCiWb9px8Tul5lkKJT-Q80yWv22pF3p62SLHvEcZEQ08B49GBGajZ74f8GF3w8975revcGGJalD2A6wak3o3RAQ2vziJNkx-3JuENhQmGEF6nP-izLvgNNd7-uxU0e1sc3BHjlD1pNGP6Qj72Zkj49TQvyO-7H0-bn8XD4_2vzfeHAmQjx6JiVcutNFgiV4BdaSwzshZcApoKJUILkjEEkCUoNDVUDEzdoFStwZbLC_Jt8d3H8HLANOqdS4DDYDyGQ9KNELxSjcrg7QJCDClF7PU-up2Jk-ZMzyXoXIKeS9BLCfni6mR96HZo3_lT6hm4PgEm5az7aDy49M6VTPGqnI3UwmEO4ugw6gQOPaB1MRembXD__cRfMaSl9A</recordid><startdate>20011001</startdate><enddate>20011001</enddate><creator>Bukowski, Radoslaw</creator><creator>McKay, Lynn</creator><creator>Shi, Shao-Qing</creator><creator>Saade, George R.</creator><creator>Garfield, Robert E.</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20011001</creationdate><title>The effects of cervical application of inhibitors of inducible nitric oxide synthase, cyclooxygenase-1, and cyclooxygenase-2 on delivery in rats</title><author>Bukowski, Radoslaw ; McKay, Lynn ; Shi, Shao-Qing ; Saade, George R. ; Garfield, Robert E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c373t-50581d3ae4e19ceb4ad0a36213cea5e3ec8c300ecc34c9ea6c50ca67e398ae813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Administration, Topical</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>cervical ripening</topic><topic>Cervical Ripening - drug effects</topic><topic>Cervix Uteri - drug effects</topic><topic>Cervix Uteri - physiology</topic><topic>cyclooxygenase inhibitor</topic><topic>Cyclooxygenase Inhibitors - pharmacology</topic><topic>Delivery, Obstetric - methods</topic><topic>Female</topic><topic>Fetal Death</topic><topic>Genital system. Reproduction</topic><topic>Guanidines - pharmacology</topic><topic>Indomethacin - pharmacology</topic><topic>Inhibition</topic><topic>Medical sciences</topic><topic>Models, Animal</topic><topic>NG-Nitroarginine Methyl Ester - administration &amp; dosage</topic><topic>nitric oxide synthase inhibitor</topic><topic>Pharmacology. Drug treatments</topic><topic>Pregnancy</topic><topic>Pregnancy Outcome</topic><topic>Pregnancy, Animal</topic><topic>preterm delivery</topic><topic>Probability</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Sensitivity and Specificity</topic><topic>Statistics, Nonparametric</topic><topic>Sulfonamides - pharmacology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bukowski, Radoslaw</creatorcontrib><creatorcontrib>McKay, Lynn</creatorcontrib><creatorcontrib>Shi, Shao-Qing</creatorcontrib><creatorcontrib>Saade, George R.</creatorcontrib><creatorcontrib>Garfield, Robert E.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bukowski, Radoslaw</au><au>McKay, Lynn</au><au>Shi, Shao-Qing</au><au>Saade, George R.</au><au>Garfield, Robert E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effects of cervical application of inhibitors of inducible nitric oxide synthase, cyclooxygenase-1, and cyclooxygenase-2 on delivery in rats</atitle><jtitle>American journal of obstetrics and gynecology</jtitle><addtitle>Am J Obstet Gynecol</addtitle><date>2001-10-01</date><risdate>2001</risdate><volume>185</volume><issue>4</issue><spage>959</spage><epage>965</epage><pages>959-965</pages><issn>0002-9378</issn><eissn>1097-6868</eissn><coden>AJOGAH</coden><abstract>Objective: To investigate the effect of cervical application of nonselective and selective inhibitors of nitric oxide synthases—N -nitro-L -arginine methyl ester, L -N -iminoethyl-lysine, and aminoguanidine—as well as inhibitors of cyclooxygenases—indomethacin, and nimesulide—on timing of delivery and fetal death and disease in pregnant rats. Study Design: In a series of experimental protocols, timed-pregnant Sprague-Dawley rats (length of pregnancy, 22 days) were randomly allocated to daily cervical applications of (1) 0.04 mg (n = 6), 0.4 mg (n = 6), 4 mg (n = 6), or 40 mg (n = 6) L -N -iminoethyl-lysine or vehicle (n = 12) on days 19 to 22 of pregnancy; (2) 50 mg aminoguanidine (n = 6), 150 mg aminoguanidine (n = 6), or vehicle (n = 10) on days 19 to 22 of pregnancy; (3) 3 mg indomethacin (n = 6) or vehicle (n = 6) on days 19 to 22 of pregnancy; (4) 12.5 mg/kg nimesulide (n = 8), 25 mg/kg nimesulide (n = 8), 50 mg/kg nimesulide (n = 12), or vehicle (n = 12) on days 19 to 22 of pregnancy and 50 mg/kg nimesulide (n = 23) or vehicle (n = 23) on days 14 to 22 of pregnancy; (5) 50 mg/kg nimesulide (n = 10), 50 mg aminoguanidine plus 50 mg/kg nimesulide (n = 10), 50 mg aminoguanidine (n = 10), or vehicle (n = 10) on days 14 to 22 of pregnancy. The following variables were evaluated: proportion of animals that were delivered on day 23, time to delivery of the first pup (midnight on day 22 was considered to be 0 hour), number of stillborn pups, and average pup weight of each litter. Results: Unlike L -N -iminoethyl-lysine, aminoguanidine, and indomethacin, 50 mg/kg nimesulide applied on the cervix daily for 8 days significantly increased the proportion of animals that were delivered on day 23 (18 of 23 versus 7 of 23; P =.003) and the time to delivery of the first pup by a mean of 10.8 hours (P &lt;.001). Shorter treatment with nimesulide for 4 days increased only the time to delivery of the first pup at the 25-mg/kg dosage (P =.008). Simultaneous application of aminoguanidine and nimesulide significantly (P =.008) prolonged pregnancy to a degree similar to nimesulide alone. The experiment with N -nitro-L -arginine methyl ester was aborted because of severe maternal side effects. Unlike pups in the L -N -iminoethyl-lysine, aminoguanidine, and nimesulide groups, significantly more pups in the indomethacin group died in utero compared with the control group (36.1% versus 3.1%; P &lt;.001), and the surviving pups had lower birth weights (P &lt;.001). Conclusions: In an animal model, nimesulide was effective in delaying the onset of labor, was well tolerated during pregnancy, and affected cervical ripening directly independent of progesterone withdrawal. Conversely, cervical application of nitric oxide synthase and nonselective cyclooxygenase inhibitors do not extend the duration of pregnancy in the dosages studied, and some are associated with significant adverse effects in the mothers and fetuses. (Am J Obstet Gynecol 2001;185: 959-65.)</abstract><cop>Philadelphia, PA</cop><pub>Mosby, Inc</pub><pmid>11641685</pmid><doi>10.1067/mob.2001.116723</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9378
ispartof American journal of obstetrics and gynecology, 2001-10, Vol.185 (4), p.959-965
issn 0002-9378
1097-6868
language eng
recordid cdi_proquest_miscellaneous_72215979
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Administration, Topical
Animals
Biological and medical sciences
cervical ripening
Cervical Ripening - drug effects
Cervix Uteri - drug effects
Cervix Uteri - physiology
cyclooxygenase inhibitor
Cyclooxygenase Inhibitors - pharmacology
Delivery, Obstetric - methods
Female
Fetal Death
Genital system. Reproduction
Guanidines - pharmacology
Indomethacin - pharmacology
Inhibition
Medical sciences
Models, Animal
NG-Nitroarginine Methyl Ester - administration & dosage
nitric oxide synthase inhibitor
Pharmacology. Drug treatments
Pregnancy
Pregnancy Outcome
Pregnancy, Animal
preterm delivery
Probability
Rats
Rats, Sprague-Dawley
Sensitivity and Specificity
Statistics, Nonparametric
Sulfonamides - pharmacology
Treatment Outcome
title The effects of cervical application of inhibitors of inducible nitric oxide synthase, cyclooxygenase-1, and cyclooxygenase-2 on delivery in rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T18%3A32%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effects%20of%20cervical%20application%20of%20inhibitors%20of%20inducible%20nitric%20oxide%20synthase,%20cyclooxygenase-1,%20and%20cyclooxygenase-2%20on%20delivery%20in%20rats&rft.jtitle=American%20journal%20of%20obstetrics%20and%20gynecology&rft.au=Bukowski,%20Radoslaw&rft.date=2001-10-01&rft.volume=185&rft.issue=4&rft.spage=959&rft.epage=965&rft.pages=959-965&rft.issn=0002-9378&rft.eissn=1097-6868&rft.coden=AJOGAH&rft_id=info:doi/10.1067/mob.2001.116723&rft_dat=%3Cproquest_cross%3E72215979%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72215979&rft_id=info:pmid/11641685&rft_els_id=S0002937801446011&rfr_iscdi=true